Goodwin Procter LLP advised MyoKardia, Inc. on the deal, while Ropes & Gray represented LianBio. MyoKardia, Inc. (Nasdaq: MYOK) and LianBio announced that they have entered…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
